ArticleOncotarget2017
Overriding TKI resistance of renal cell carcinoma by combination therapy with IL-6 receptor blockade.
Kei Ishibashi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
38 papers cite it
this papercites it
ArticleOncotarget2017
Kei Ishibashi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.